For this, we have previously discovered new cell surface biomarkers, a carcinoembryonic antigen-associated cell adhesion molecule 6 (CEACAM6 or CD66c), of breast cancer-derived cancer stem cells (BCSCs) through omics-based analysis, which is the first report of its function in BCSCs [23]. Here, CEACAM6 is linked to breast cancer.